Emerging Players in the Trastuzumab Biosimilars Market: Insights for 2024 Regulatory Landscape of Trastuzumab Biosimilars: Updates and Implications for 2024
Trastuzumab - Biosimilars Insight, 2024
Trastuzumab, a monoclonal antibody targeting HER2-positive breast cancer, has revolutionized the treatment landscape since its approval. As patents for the originator product have begun to expire, biosimilar versions of Trastuzumab have emerged, aiming to provide...
0 Shares
34 Views
0 Reviews